| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Creativity Management and Time Pressure |
|
Main Subject - Creativity Management and Time Pressure
There is a pervasive belief that time pressure stimulates creativity. This is both true and false. There are a number of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product forces at work: a) Time pressure increases creative output. By forcing idea production, setting goals and incremental d ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in adlines, a greater number of ideas are produced than if a “do your best” approach is taken. If a leader asks particpants lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. n an idea generating session to address a problem and think of at least 5 ideas every half an hour, then 80 ideas are pro here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe uced by one individual and 1600 are produced by 20 individuals at the end of an average working day. This level of output d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is conscious and would not be produced normally. b) Time pressure encourages prolific production and therefore the proba ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ility of generating good ideas increases. It can be said with great confidence that quality of output is closely related easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi o quantity. The best single creative product tends to appear at that point in the career when the creator is being most p nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically olific. c) Forcing output pushes individuals along the experience curve, refines their methodology, builds competencies and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nd knowledge and improves performance. Screenwriters know that they are likely to produce more, better quality work faste ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi if they set themselves a schedule of a certain number of pages per day. d) Motivation is critical to creativity. If a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a erson is intrinsically motivated, time pressure may be a synergistic extrinsic motivator. If the person is not intrinsica dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ly motivated then it may turn out to be a non-synergistic extrinsic motivator, which reduces the level of engagement in t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e endeavour. e) Short term time pressure may be bad in that it does not allow the mind to engage in the endeavour at var tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ous cognitive levels. It does not allow rich ideas to formulate through the process of incubation. Intrinsically motivate t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel individuals will benefit from short term time pressure and goals (sets cognitive forces in motion) and will generate ric ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust er ideas through incubation over the longer term. This topic is covered in depth in the MBA dissertation on Managing Cre y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tivity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit, Good Idea Generator Softwa . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e and Power Point Presentation) from http://www.managing-creativity.com Kal Bishop, MBA ******************************* elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ** You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Indian Textile Machinery Industry How Productive are your Meetings?
|